Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |